T1	Participants 334 375	patients with acute myocardial infarction
T2	Participants 457 661	follow-up study to 5 years of a randomized, double-blinded trial was conducted among 368 patients with first ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention (PCI).
